Allarity Therapeutics, Inc.
ALLR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $658 | $3 | $61 |
| - Cash | $20 | $0 | $2 | $20 |
| + Debt | $1 | $1 | $4 | $1 |
| Enterprise Value | -$16 | $659 | $4 | $43 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$24 | -$11 | -$17 | -$26 |
| % Margin | – | – | – | – |
| Net Income | -$25 | -$12 | -$16 | -$27 |
| % Margin | – | – | – | – |
| EPS Diluted | -15.791 | -6,153.264 | -1,856,055 | -3,520,104 |
| % Growth | 99.7% | 99.7% | 47.3% | – |
| Operating Cash Flow | -$17 | -$13 | -$17 | -$15 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$18 | -$13 | -$17 | -$15 |